Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant and Alcohol Interaction Study
NCT03483636Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lemborexant in Insomnia (4 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Change from baseline in body sway at 12 weeks and Change from baseline in Power of Attention at 12 weeks. Started Mar 2018; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03483636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03483636.